Screened 2026-08-24 · the tape above runs as of 16:37 UTC · 29 Aug · two dates, stated on purpose · verdict and workings shown in full · never trimmed
The Label · The Season, Not the Day
This name holds its distribution label.
Best Buy holds its Distribution at $87.48. Consolidating, no directional conviction, held for 10 days.
As held on the ledger · 2026-08-24
Phase
Distribution · caution
Quantitative state
Consolidating, no directional conviction, held for 10 days
Price at the screen
$87.48
Valuation
16.20 trailing · 12.35 forward price to earnings
Values screen
PASS· score 84.6
Beta
1.32
The Workings
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
28.17%
Below 33%
Interest-bearing debt is just 28.2% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
0.00%
Below 33%
Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit.
Pass
Receivables
18.96%
Below 49%
Money owed to the company is 19.0% of assets, under the 49% limit.
Pass
Revenue purity
0.00%
Below 5%
Only 0.0% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is Worth
The Fair Value Range
Our framework reads OPPORTUNITY: it trades at roughly a 9% discount to our $95.00 fair value, weak competitive moat, 1.90% revenue growth.
Fair value range in USD, drawn from the 2026-08-24 screen. The gold marker is the market price at the same screen. A 8.6% margin of safety to the base estimate.
Third-party analyst targets: 20 covering, consensus Hold. The average target sits −3% from the screen price.
Reading the gap · Our model sees value the Street hasn't fully caught up to yet.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-08-24 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Tech shelves still draw weekend crowds
Walk into any Best Buy on a Saturday and families still linger over laptops and phones in person. That hands-on habit keeps the tills ringing even as pure online rivals pile in.
The shares sit 5 percent below our fair value at 12.1 times forward earnings. A 39 percent return on equity and a clean ethical screen stand out against 2 percent revenue growth and a 3 percent profit margin.
Yet the moat is weak and the business sits squarely in a cyclical corner. The low multiple may simply mark peak earnings rather than a bargain, and twenty analysts cluster around a hold with an $80 target. Analysis, not advice.
The risks · The things to watch: it already moves more than the market on an average day.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
BBY trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-08-27Distribution$87.48+0.0%Entry 12
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are up 8%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (20 analysts) rates it hold, with a mean price target of $83. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are up 8%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (20 analysts) rates it hold, with a mean price target of $83. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-25Markup$87.48+9.3%Entry 10
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 9.3% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are up 8%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (20 analysts) rates it hold, with a mean price target of $83. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-24Markup$80.02+0.0%Entry 9
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are up 8%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (20 analysts) rates it hold, with a mean price target of $72. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-23Markup$80.02+0.0%Entry 8
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are up 8%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (20 analysts) rates it hold, with a mean price target of $72. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-22Markup$80.02+0.0%Entry 7
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are up 8%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (20 analysts) rates it hold, with a mean price target of $72. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-21Markup$80.02+0.0%Entry 6
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are up 8%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (20 analysts) rates it hold, with a mean price target of $72. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-20Markup · changed$80.02-6.3%Entry 5
The framework has shifted from accumulation to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 6.3% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are up 8%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (20 analysts) rates it hold, with a mean price target of $72. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from markup to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 19.4% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are up 8%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (20 analysts) rates it hold, with a mean price target of $72.
2026-07-18Markup$71.54+0.0%Entry 3
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are up 8%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (20 analysts) rates it hold, with a mean price target of $72.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
